Trapping Moving Targets with Small Molecules
- 10 April 2009
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 324 (5924) , 213-215
- https://doi.org/10.1126/science.1169378
Abstract
Structure-based drug design traditionally uses static protein models as inspirations for focusing on “active” site targets. Allosteric regulation of biological macromolecules, however, is affected by both conformational and dynamic properties of the protein or protein complex and can potentially lead to more avenues for therapeutic development. We discuss the advantages of searching for molecules that conformationally trap a macromolecule in its inactive state. Although multiple methodologies exist to probe protein dynamics and ligand binding, our current discussion highlights the use of nuclear magnetic resonance spectroscopy in the drug discovery and design process.Keywords
This publication has 40 references indexed in Scilit:
- Binding of Small-Molecule Ligands to Proteins: “What You See” Is Not Always “What You Get”Structure, 2009
- Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMXProceedings of the National Academy of Sciences, 2009
- Intrinsically Disordered Proteins in Human Diseases: Introducing the D2ConceptAnnual Review of Biophysics, 2008
- Simultaneous Detection and Deconvolution of Congested NMR Spectra Containing Three Isotopically Labeled SpeciesJournal of the American Chemical Society, 2008
- Allostery: Absence of a Change in Shape Does Not Imply that Allostery Is Not at PlayJournal of Molecular Biology, 2008
- Reaching for high-hanging fruit in drug discovery at protein–protein interfacesNature, 2007
- Dynamic personalities of proteinsNature, 2007
- A common allosteric site and mechanism in caspasesProceedings of the National Academy of Sciences, 2006
- Intrinsically unstructured proteins and their functionsNature Reviews Molecular Cell Biology, 2005
- Small-molecule inhibitors of protein–protein interactions: progressing towards the dreamNature Reviews Drug Discovery, 2004